Sipuleucel-T in Metastatic Castration-Resistant Prostate CancerProfile Report

被引：0
|
作者：
Greg L. Plosker
机构：
[1] Adis,
[2] a Wolters Kluwer Business,undefined
来源：
BioDrugs | 2011年 / 25卷
关键词：
Prostate Cancer; Prostatic Acid Phosphatase; Metastatic CRPC; Therapeutic Cancer Vaccine; Leukapheresis Product;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：255 / 256
页数：1
相关论文
共 50 条
  • [21] Advancing therapies in metastatic castration-resistant prostate cancer
    Baciarello, Giulia
    Gizzi, Marco
    Fizazi, Karim
    EXPERT OPINION ON PHARMACOTHERAPY, 2018, 19 (16) : 1797 - 1804
  • [22] The changing landscape in metastatic castration-resistant prostate cancer
    Leibowitz-Amit, Raya
    Joshua, Anthony M.
    CURRENT OPINION IN SUPPORTIVE AND PALLIATIVE CARE, 2013, 7 (03) : 243 - 248
  • [23] Sipuleucel-T for prostate cancer: the immunotherapy era has commenced
    Buonerba, Carlo
    Ferro, Matteo
    Di Lorenzo, Giuseppe
    EXPERT REVIEW OF ANTICANCER THERAPY, 2011, 11 (01) : 25 - 28
  • [24] Bispecific PSMA antibodies and CAR-T in metastatic castration-resistant prostate cancer
    Zarrabi, Kevin K.
    Narayan, Vivek
    Mille, Patrick J.
    Zibelman, Matthew R.
    Miron, Benjamin
    Bashir, Babar
    Kelly, William Kevin
    THERAPEUTIC ADVANCES IN UROLOGY, 2023, 15
  • [25] Recurrent Disseminated Intravascular Coagulation in Metastatic Castration-Resistant Prostate Cancer: A Case Report
    Giszas, Benjamin
    Fritzenwanger, Michael
    Grimm, Marc-Oliver
    Stallmach, Andreas
    Reuken, Philipp A.
    DIAGNOSTICS, 2022, 12 (10)
  • [26] Circulating Tumor Cells in Metastatic Castration-Resistant Prostate Cancer
    Rini, Brian I.
    CURRENT ONCOLOGY REPORTS, 2009, 11 (03) : 163 - 164
  • [27] Targeting the androgen receptor in metastatic castration-resistant prostate cancer
    Aragon-Ching, Jeanny B.
    FUTURE ONCOLOGY, 2014, 10 (03) : 329 - 332
  • [28] Optimal Therapy Sequencing in Metastatic Castration-Resistant Prostate Cancer
    Sausan Abouharb
    Paul G. Corn
    Current Oncology Reports, 2013, 15 : 217 - 223
  • [29] Optimal Treatment Sequence for Metastatic Castration-resistant Prostate Cancer
    Lorente, David
    Fizazi, Karim
    Sweeney, Christopher
    de Bono, Johann S.
    EUROPEAN UROLOGY FOCUS, 2016, 2 (05): : 488 - 498
  • [30] The role of cabazitaxel in the treatment of metastatic castration-resistant prostate cancer
    Tsao, Che-Kai
    Cutting, Elena
    Martin, Jacob
    Oh, William K.
    THERAPEUTIC ADVANCES IN UROLOGY, 2014, 6 (03) : 97 - 104
12345